Type

Range

Units

Status

Start Date

End Date

Financing

Brief description/objective

Prospective Randomized, Multi-centre, International, Open Label, Clinical trial comparing the Selution DEB strategy versus any CE-marked DES strategy.
The study will test:
1) for non-inferiority of a DEB plus provisional DES treatment strategy versus a systematic DES strategy with respect to the primary endpoint of TVF at 12 months.
2) for long-term non-inferiority at 5 years of the DEB strategy with TVF as an endpoint and if met for long-term superiority at 5 years
All Subjects will be followed for clinical outcomes at 30 days, 6 months, 1 2, 3, 4 and 5 years.